Brain volume loss (BVL) has gained increasing interest for monitoring tissue damage in neurodegenerative diseases including multiple sclerosis (MS). In this longitudinal study, 117 healthy participants (age range 37.3â82.6 years) received at least 2 magnetic resonance imaging examinations. BVL (in %) was determined with the Structural Image Evaluation using Normalisation of Atrophy/FMRIB Software Library and annualized. Mean BVL per year was 0.15%, 0.30%, 0.46%, and 0.61% at ages 45, 55, 65, and 75 years, respectively. The corresponding BVL per year values of the age-dependent 95th percentiles were 0.52%, 0.77%, 1.05% and 1.45%. Pathological BVL can be assumed if an individual BVL per year exceeds these thresholds for a given age. The mean ...
Background: Baseline brain volume (BV) is predictive at a group level but is difficult to interpret ...
We provide here normative values of yearly percentage brain volume change (PBVC/y) as obtained with ...
Objective: To define values of normalized brain volume (NBV) that can be categorized as low, medium,...
Brain volume loss (BVL) has gained increasing interest for monitoring tissue damage in neurodegenera...
Brain volume loss (BVL) has gained increasing interest for monitoring tissue damage in neurodegenera...
Brain volume loss (BVL) has gained increasing interest for monitoring tissue damage in neurodegenera...
Background: Volumetric MRI surrogate markers of disease progression are lacking. Objective: To estab...
Background: In multiple sclerosis (MS), brain atrophy depicted by magnetic resonance imaging reflect...
Multiple sclerosis (MS) is a chronic inflammatory demyelinating and degenerative disorder of the cen...
Introduction: Several recent studies indicate that deep gray matter or thalamic volume loss (VL) mig...
Objective To assess whether it is feasible to establish specific cut-off values able to discriminate...
BACKGROUND Measurements of brain volume loss (BVL) in individual patients are currently discussed co...
Background: Baseline brain volume (BV) is predictive at a group level but is difficult to interpret ...
We provide here normative values of yearly percentage brain volume change (PBVC/y) as obtained with ...
Objective: To define values of normalized brain volume (NBV) that can be categorized as low, medium,...
Brain volume loss (BVL) has gained increasing interest for monitoring tissue damage in neurodegenera...
Brain volume loss (BVL) has gained increasing interest for monitoring tissue damage in neurodegenera...
Brain volume loss (BVL) has gained increasing interest for monitoring tissue damage in neurodegenera...
Background: Volumetric MRI surrogate markers of disease progression are lacking. Objective: To estab...
Background: In multiple sclerosis (MS), brain atrophy depicted by magnetic resonance imaging reflect...
Multiple sclerosis (MS) is a chronic inflammatory demyelinating and degenerative disorder of the cen...
Introduction: Several recent studies indicate that deep gray matter or thalamic volume loss (VL) mig...
Objective To assess whether it is feasible to establish specific cut-off values able to discriminate...
BACKGROUND Measurements of brain volume loss (BVL) in individual patients are currently discussed co...
Background: Baseline brain volume (BV) is predictive at a group level but is difficult to interpret ...
We provide here normative values of yearly percentage brain volume change (PBVC/y) as obtained with ...
Objective: To define values of normalized brain volume (NBV) that can be categorized as low, medium,...